BARBED vs. STANDARD Suture for Colporrhaphy at the End of Laparoscopic Hysterectomy
Launched by UNIVERSITA DI VERONA · Apr 15, 2023
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a special type of suture, called a barbed suture, to see if it helps reduce complications after a laparoscopic hysterectomy, which is a common surgery for women. Specifically, the trial will compare barbed sutures to standard sutures to determine if they lead to fewer problems with the vaginal cuff, which is a part of the body that can sometimes have complications after surgery. Complications like dehiscence (when the tissue separates), bleeding, or infection can occur in a small percentage of patients, so finding ways to prevent these issues is important.
To be eligible for this study, participants must be women over 18 years old who are scheduled for an elective laparoscopic hysterectomy due to non-cancerous conditions. Those who have had emergency surgeries, are undergoing treatment for cancer, or have certain allergies or prior treatments that could affect the study won't be included. If someone joins the trial, they can expect to receive either the barbed or standard suture during their surgery, and their recovery will be monitored to see how well each type of suture works. This research could help improve surgical outcomes for many women in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing elective total laparoscopic hysterectomy
- • Surgery performed for the treatment of benign pathology
- • Age \> 18 years
- • Surgery performed by laparoscopy
- • Signature of informed consent
- Exclusion Criteria:
- • Patients undergoing emergent surgery
- • Patients candidates for hysterectomy for oncological indication
- • Patients who underwent previous radiation therapy
- • Patients allergic to the suture material used in the study
- • Patients unable to express adequate informed consent to participate in the study
About Universita Di Verona
The Università di Verona is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university collaborates with various healthcare professionals and institutions to explore new therapies and improve patient outcomes. Its research initiatives are driven by a multidisciplinary approach, leveraging cutting-edge technology and methodologies. The Università di Verona aims to contribute significantly to the scientific community and public health by fostering rigorous clinical studies that address pressing medical challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Verona, , Italy
Patients applied
Trial Officials
Stefano Uccella, MD, PhD
Principal Investigator
Universita di Verona
Simone Garzon, MD
Principal Investigator
Universita di Verona
Pier Carlo Zorzato, MD
Principal Investigator
Universita di Verona
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported